Pacira Biosciences Receives FDA 510K Clearance for New Iovera° Smarttip to Manage Chronic Low Back Pain via Long-Lasting Medial Branch Nerve Block
Pacira BioSciences获得FDA 51万批准,推出新款Iovera° Smarttip,通过开多的脊神经阻滞管理慢性下背痛。
Pacira Biosciences Receives FDA 510K Clearance for New Iovera° Smarttip to Manage Chronic Low Back Pain via Long-Lasting Medial Branch Nerve Block
Pacira BioSciences获得FDA 51万批准,推出新款Iovera° Smarttip,通过开多的脊神经阻滞管理慢性下背痛。
译文内容由第三方软件翻译。